12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
周一盘前交易时段，12只医疗保健股走势
Gainers
获胜者
- Celldex Therapeutics (NASDAQ:CLDX) stock increased by 30.1% to $33.8 during Monday's pre-market session. The company's market cap stands at $1.5 billion. As per the press release, Q3 earnings came out 2 days ago.
- Sensei Biotherapeutics (NASDAQ:SNSE) shares moved upwards by 21.15% to $0.84. The company's market cap stands at $22.2 million.
- Baudax Bio (NASDAQ:BXRX) shares rose 14.4% to $0.25. The company's market cap stands at $2.3 million.
- CervoMed (NASDAQ:CRVO) shares moved upwards by 14.17% to $12.48. The market value of their outstanding shares is at $70.8 million.
- Repare Therapeutics (NASDAQ:RPTX) stock increased by 13.38% to $4.32. The market value of their outstanding shares is at $181.8 million.
- OptimizeRx (NASDAQ:OPRX) shares rose 11.3% to $9.45. The market value of their outstanding shares is at $170.8 million. The company's, Q3 earnings came out today.
- Celldex 疗法 纳斯达克股票代码：CLDX）在周一的盘前交易中上涨30.1％，至33.8美元。该公司的市值为15亿美元。根据新闻稿，第三季度财报是在两天前发布的。
- 生物疗法老师 纳斯达克股票代码：SNSE）股价上涨21.15％，至0.84美元。该公司的市值为2,220万美元。
- Baudax Bio 纳斯达克股票代码：BXRX）股价上涨14.4％，至0.25美元。该公司的市值为230万美元。
- cervomed 纳斯达克股票代码：CRVO）股价上涨14.17％，至12.48美元。他们流通股的市值为7,080万美元。
- 修复疗法 纳斯达克股票代码：RPTX）股价上涨13.38％，至4.32美元。他们流通股的市值为1.818亿美元。
- OptimizerX 纳斯达克股票代码：OPRX）股价上涨11.3％，至9.45美元。他们流通股的市值为1.708亿美元。该公司今天公布了第三季度的收益。
Losers
失败者
- Cerus (NASDAQ:CERS) shares fell 20.8% to $1.37 during Monday's pre-market session. The market value of their outstanding shares is at $248.2 million. As per the news, the Q3 earnings report came out 2 days ago.
- MoonLake (NASDAQ:MLTX) shares declined by 18.1% to $42.0. The company's market cap stands at $2.2 billion.
- NexImmune (NASDAQ:NEXI) shares decreased by 14.68% to $2.5. The company's market cap stands at $2.6 million.
- Acurx Pharmaceuticals (NASDAQ:ACXP) shares fell 10.67% to $2.93. The company's market cap stands at $38.1 million.
- Altamira Therapeutics (NASDAQ:CYTO) shares declined by 9.47% to $0.14. The company's market cap stands at $1.0 million.
- Kazia Therapeutics (NASDAQ:KZIA) shares declined by 9.28% to $0.43. The company's market cap stands at $10.0 million. See Also:
- 塞鲁斯 纳斯达克股票代码：CERS）股价在周一的盘前交易中下跌20.8％，至1.37美元。他们流通股的市值为2.482亿美元。根据消息，第三季度收益报告是在2天前发布的。
- 月湖 纳斯达克股票代码：MLTX）股价下跌18.1％，至42.0美元。该公司的市值为22亿美元。
- nexiMune 纳斯达克股票代码：NEXI）股价下跌14.68％，至2.5美元。该公司的市值为260万美元。
- Acurx 制药 纳斯达克股票代码：ACXP）股价下跌10.67％，至2.93美元。该公司的市值为3,810万美元。
- 阿尔塔米拉疗法 纳斯达克股票代码：CYTO）股价下跌9.47％，至0.14美元。该公司的市值为100万美元。
- 卡齐亚疗法 纳斯达克股票代码：KZIA）股价下跌9.28％，至0.43美元。该公司的市值为1,000万美元。 另请参阅：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。